Invention Grant
- Patent Title: Methods involving PDGFRBETA inhibitors
- Patent Title (中): 涉及PDGFRBETA抑制剂的方法
-
Application No.: US13498827Application Date: 2010-09-28
-
Publication No.: US08933037B2Publication Date: 2015-01-13
- Inventor: Lukas Kenner , Daniela Laimer
- Applicant: Lukas Kenner , Daniela Laimer
- Applicant Address: AT Vienna
- Assignee: Medizinische Universitat Wien
- Current Assignee: Medizinische Universitat Wien
- Current Assignee Address: AT Vienna
- Agency: Fulbright & Jaworski LLP
- Priority: EP09171469 20090928
- International Application: PCT/EP2010/064367 WO 20100928
- International Announcement: WO2011/036305 WO 20110331
- Main IPC: A61P35/00
- IPC: A61P35/00 ; A61K31/506 ; A61K31/404 ; A61K31/4439 ; A61K45/06
Abstract:
The invention refers to PDGFRbeta inhibitor for use in the antiproliferative treatment of T-cell lymphoma, in particular NHL, ALCL and PTCL.
Public/Granted literature
- US20120252736A1 METHODS INVOLVING PDGFRBETA INHIBITORS Public/Granted day:2012-10-04
Information query
IPC分类:
| A | 人类生活必需 |
| A61 | 医学或兽医学；卫生学 |
| A61P | 化合物或药物制剂的特定治疗活性 |
| A61P35/00 | 抗肿瘤药 |
